U.S. HHS says cannabis should be moved to Schedule III, Marijuana Moment reports

The U.S. Department of Health and Human Services is recommending cannabis be moved from Schedule I to Schedule III under the Controlled Substances Act after finishing a scientific review under a directive from President Joe Biden, Marijuana Moment’s Kyle Jaeger reports, citing the agency. HHS has given its recommendation to the Drug Enforcement Administration, which will have the final say, but the scientific analysis along with increasing political support for reform may influence the DEA. Publicly traded companies in the space include Aurora Cannabis (ACB), CV Sciences (CVSI), CannTrust Holdings (CNTTF), Canopy Growth (CGC), Cronos Group (CRON), Goodness Growth (GDNSF), Green Thumb Industries (GTBIF), IGC Pharma (IGC), Tilray (TLRY), Trees Corporation (CANN), Trulieve Cannabis (TCNNF) and Zynerba (ZYNE).